Reduction of coronary events with aspirin in older patients with prior myocardial infarction treated with and without statins

Wilbert S. Aronow, Chul Ahn

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

In an observational prospective study of 1,410 patients (mean age, 81 ± 9 years) with prior myocardial infarction, no contraindications to aspirin, and a serum low-density lipoprotein cholesterol level of 125 mg/dL or higher, 832 (59%) were treated with aspirin. At the 36-month follow-up evaluation, the incidence of new coronary events was 52% in persons treated with aspirin versus 70% in those who were not treated with aspirin (P < 0.0001). The stepwise Cox regression model showed that significant independent predictors of new coronary events were age (risk ratio, 1.05 for each 1-year increase), current cigarette smoking (risk ratio, 2.7), hypertension (risk ratio, 1.7), diabetes mellitus (risk ratio, 2.2), initial serum low-density lipoprotein cholesterol level (risk ratio, 1.01 for each 1-mg/dL increase), initial serum high-density lipoprotein cholesterol level (risk ratio, 0.96 for each 1-mg/dL increase), use of statins (risk ratio, 0.46), and use of aspirin (risk ratio, 0.48).

Original languageEnglish (US)
Pages (from-to)159-161
Number of pages3
JournalHeart Disease
Volume4
Issue number3
StatePublished - 2002

Fingerprint

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Aspirin
Odds Ratio
Myocardial Infarction
LDL Cholesterol
Serum
Proportional Hazards Models
HDL Cholesterol
Observational Studies
Diabetes Mellitus
Smoking
Prospective Studies
Hypertension
Incidence

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Reduction of coronary events with aspirin in older patients with prior myocardial infarction treated with and without statins. / Aronow, Wilbert S.; Ahn, Chul.

In: Heart Disease, Vol. 4, No. 3, 2002, p. 159-161.

Research output: Contribution to journalArticle

@article{00cc60f6b00741a2b2e21d959fa39cfa,
title = "Reduction of coronary events with aspirin in older patients with prior myocardial infarction treated with and without statins",
abstract = "In an observational prospective study of 1,410 patients (mean age, 81 ± 9 years) with prior myocardial infarction, no contraindications to aspirin, and a serum low-density lipoprotein cholesterol level of 125 mg/dL or higher, 832 (59{\%}) were treated with aspirin. At the 36-month follow-up evaluation, the incidence of new coronary events was 52{\%} in persons treated with aspirin versus 70{\%} in those who were not treated with aspirin (P < 0.0001). The stepwise Cox regression model showed that significant independent predictors of new coronary events were age (risk ratio, 1.05 for each 1-year increase), current cigarette smoking (risk ratio, 2.7), hypertension (risk ratio, 1.7), diabetes mellitus (risk ratio, 2.2), initial serum low-density lipoprotein cholesterol level (risk ratio, 1.01 for each 1-mg/dL increase), initial serum high-density lipoprotein cholesterol level (risk ratio, 0.96 for each 1-mg/dL increase), use of statins (risk ratio, 0.46), and use of aspirin (risk ratio, 0.48).",
author = "Aronow, {Wilbert S.} and Chul Ahn",
year = "2002",
language = "English (US)",
volume = "4",
pages = "159--161",
journal = "Heart Disease",
issn = "1521-737X",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Reduction of coronary events with aspirin in older patients with prior myocardial infarction treated with and without statins

AU - Aronow, Wilbert S.

AU - Ahn, Chul

PY - 2002

Y1 - 2002

N2 - In an observational prospective study of 1,410 patients (mean age, 81 ± 9 years) with prior myocardial infarction, no contraindications to aspirin, and a serum low-density lipoprotein cholesterol level of 125 mg/dL or higher, 832 (59%) were treated with aspirin. At the 36-month follow-up evaluation, the incidence of new coronary events was 52% in persons treated with aspirin versus 70% in those who were not treated with aspirin (P < 0.0001). The stepwise Cox regression model showed that significant independent predictors of new coronary events were age (risk ratio, 1.05 for each 1-year increase), current cigarette smoking (risk ratio, 2.7), hypertension (risk ratio, 1.7), diabetes mellitus (risk ratio, 2.2), initial serum low-density lipoprotein cholesterol level (risk ratio, 1.01 for each 1-mg/dL increase), initial serum high-density lipoprotein cholesterol level (risk ratio, 0.96 for each 1-mg/dL increase), use of statins (risk ratio, 0.46), and use of aspirin (risk ratio, 0.48).

AB - In an observational prospective study of 1,410 patients (mean age, 81 ± 9 years) with prior myocardial infarction, no contraindications to aspirin, and a serum low-density lipoprotein cholesterol level of 125 mg/dL or higher, 832 (59%) were treated with aspirin. At the 36-month follow-up evaluation, the incidence of new coronary events was 52% in persons treated with aspirin versus 70% in those who were not treated with aspirin (P < 0.0001). The stepwise Cox regression model showed that significant independent predictors of new coronary events were age (risk ratio, 1.05 for each 1-year increase), current cigarette smoking (risk ratio, 2.7), hypertension (risk ratio, 1.7), diabetes mellitus (risk ratio, 2.2), initial serum low-density lipoprotein cholesterol level (risk ratio, 1.01 for each 1-mg/dL increase), initial serum high-density lipoprotein cholesterol level (risk ratio, 0.96 for each 1-mg/dL increase), use of statins (risk ratio, 0.46), and use of aspirin (risk ratio, 0.48).

UR - http://www.scopus.com/inward/record.url?scp=0036089328&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036089328&partnerID=8YFLogxK

M3 - Article

C2 - 12028600

AN - SCOPUS:0036089328

VL - 4

SP - 159

EP - 161

JO - Heart Disease

JF - Heart Disease

SN - 1521-737X

IS - 3

ER -